BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $669,312 | +93.6% | 17,735 | +133.7% | 0.09% | +97.7% |
| Q2 2023 | $345,739 | +22.3% | 7,589 | +8.9% | 0.04% | +15.8% |
| Q1 2023 | $282,642 | +0.2% | 6,968 | +25.9% | 0.04% | -5.0% |
| Q4 2022 | $282,189 | +12.4% | 5,536 | +18.6% | 0.04% | +5.3% |
| Q3 2022 | $251,000 | -8.7% | 4,666 | +8.8% | 0.04% | +8.6% |
| Q2 2022 | $275,000 | -3.8% | 4,288 | +16.4% | 0.04% | +6.1% |
| Q1 2022 | $286,000 | -9.5% | 3,684 | 0.0% | 0.03% | -5.7% |
| Q4 2021 | $316,000 | +6.0% | 3,684 | -0.7% | 0.04% | -2.8% |
| Q3 2021 | $298,000 | -2.9% | 3,710 | -2.6% | 0.04% | -2.7% |
| Q2 2021 | $307,000 | -7.5% | 3,809 | -3.2% | 0.04% | -15.9% |
| Q1 2021 | $332,000 | +6.1% | 3,936 | +0.9% | 0.04% | 0.0% |
| Q4 2020 | $313,000 | -0.3% | 3,899 | 0.0% | 0.04% | -12.0% |
| Q3 2020 | $314,000 | +1.3% | 3,899 | +8.4% | 0.05% | -7.4% |
| Q2 2020 | $310,000 | -20.5% | 3,598 | -25.1% | 0.05% | -35.7% |
| Q1 2020 | $390,000 | -19.1% | 4,805 | -16.7% | 0.08% | +3.7% |
| Q4 2019 | $482,000 | -9.7% | 5,765 | -5.6% | 0.08% | -19.0% |
| Q3 2019 | $534,000 | +6.6% | 6,108 | -0.1% | 0.10% | -2.0% |
| Q2 2019 | $501,000 | +2.9% | 6,117 | +2.0% | 0.10% | +21.4% |
| Q1 2019 | $487,000 | +23.3% | 5,995 | +0.0% | 0.08% | +3.7% |
| Q4 2018 | $395,000 | -12.0% | 5,994 | +2.9% | 0.08% | +6.6% |
| Q3 2018 | $449,000 | +21.0% | 5,823 | +15.9% | 0.08% | +13.4% |
| Q2 2018 | $371,000 | +4.2% | 5,022 | -8.3% | 0.07% | +3.1% |
| Q1 2018 | $356,000 | +2.0% | 5,474 | +1.3% | 0.06% | +1.6% |
| Q4 2017 | $349,000 | – | 5,402 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |